HAI
UTHR icon

Hennessy Advisors Inc’s United Therapeutics UTHR Stock Holding History

Hennessy Advisors Inc’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.98M Sell
5,500
-100
-2% -$56.3K 0.1% 199
2026
Q1 		$3.32M Buy
+5,600
New +$2.79M 0.12% 181

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Hennessy Advisors Inc's UTHR Position: Q2 2026 in Review

Hennessy Advisors Inc reduced its United Therapeutics (UTHR) stake by 1.8% in Q2 2026, selling an estimated $56.3K and leaving 5,500 shares worth $2.98M. The position accounts for 0.1% of the portfolio, ranked #199.

Hennessy Advisors Inc first reported a position in UTHR in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.32M in Q1 2026. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Hennessy Advisors Inc held 5,500 shares of United Therapeutics worth $2.98M as of Q2 2026.
  • Hennessy Advisors Inc sold 100 United Therapeutics shares in Q2 2026, an estimated $56.3K.
  • United Therapeutics made up 0.1% of Hennessy Advisors Inc's portfolio in Q2 2026, its #199 holding.
  • Hennessy Advisors Inc first reported a position in United Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Hennessy Advisors Inc's United Therapeutics position peaked at $3.32M in Q1 2026.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Hennessy Advisors Inc's 13F filing for Q2 2026, filed 16 Jul 2026.